Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2527-2533

  Faggiano, Antongiulio ^a   Pivonello, Rosario ^a   Spiezia, Stefano ^b   De Martino, Maria Cristina ^a   Filippella, Mariagiovanna ^a   Di Somma, Carolina ^a   Lombardi, Gaetano ^a   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b S Maria degli Incurabili Hospital of Naples   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERY DIAMETER; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMMON CAROTID ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CUSHING DISEASE; DISEASE ACTIVITY; DISEASE MARKER; DOPPLER FLOWMETRY; EVALUATION; FEMALE; HIP; HUMAN; HYPERADRENOCORTICISM; MALE; PARAMETER; PREDICTION; PRIORITY JOURNAL; REMISSION; STATISTICAL SIGNIFICANCE; THICKNESS;

EID: 0038305844     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021558     Document Type: Article

References (32)

1. Aron DC, Findling JW, Tyrrell JB 1987 Cushing's disease. Endocrinol Metab Clin North Am 16:705-730
2. Etxabe J, Vazquez JA 1994 Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479-484
3. Orth DN, Kovacs WJ, DeBold CR 1998 The adrenal cortex. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology. Philadelphia: W. B. Saunders; 517-664
4. Ambrosi B, Sartorio A, Pizzocaro A, Passini E, Bottasso B, Federici A 2000 Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma. Exp Clin Endocrinol Diabetes. 108:294-298
5. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G 1999 Persistence of increased cardiovascular risk in patients with Cushing's disease after 5 years of Cushing's disease utilizing stable isotope techniques. J Clin Endocrinol Metab 84:2664-2672
6. Reinartz G, Angermaier A, Buchfelder M, Fahlbusch R, Georgieff M 1995 Pre- and postoperative investigations of hepatic glucose production and leucine turnover in Cushing's disease utilizing stable isotope techniques. Horm Metab Res 27:425-431
7. 1983 Obesity. A report of the Royal College of Physicians. J R Coll Physicians Lond 17:5-65
8. Yanovski SZ 1993 A practical approach to treatment of the obese patient. Arch Fam Med 2:309-316
9. World Health Organization 1996 Hypertension control. Report of a WHO expert committee. Tech Rep Ser 862:1-83
10. Castelli WP 1996 Lipid, risk factors and ischaernic heart disease. Atherosclerosis. 124(Suppl):S1-S9
11. 1984 Consensus conference: treatment of hypertriglyceridemia. JAMA 251:1196-1200
12. 1988 Report of the National Cholesterol Education Program expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 148:36-39
13. The DECODE study group on behalf of the European Diabetes Epidemiology Group 1999 Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617-621
14. Gamble G, Zorn J, Sanders G, MacMahon S, Sharpe N 1994 Estimation of arterial stiffness, compliance and distensibility from M-Mode ultrasound measurements of the common carotid artery. Stroke 25:11-16
15. Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM 2000 Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest 23:145-150
16. Calles Escandon J, Garcia Rubi E, Mirza S, Mortensen A 1999 Type 2 diabetes: one disease, multiple cardiovascular risk factors. Coron Artery Dis 10:23-30
17. Stamler J, Pick R, Katz LN 1954 Effects of cortisone, hydrocortisone and corticotropin on lipemia, glycemia and atherogenesis in cholesterol-fed chicks. Circulation 10:237-246
18. Rosenfeld S, Marmorston J, Sobel H, White AE 1960 Enhancement of experimental atherosclerosis by ACTH in the dog. Proc Soc Exp Biol Med 103:83-86
19. Lorenzen I, Hansen LK 1967 Effect of glucocorticoids on human vascular connective tissue. Vasc Dis 4:335-341
20. Wajchenberg BL 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738
21. Raeven GM 1988 Role of insulin resistance in human disease. Diabetes 37:1595-1607
22. Karnieri E, Cohen P, Barzilai N, Ish-Shalom Z, Armoni M, Rafaelov R, Barzilai D 1985 Insulin resistance in Cushing's syndrome. Horm Metab Res 17:518-521
23. Calles-Escandon J, Cipolla M 2001 Diabetes and endothelial dysfunction: a clinical prospective. Endocr Rev 22:36-52
24. Cosentino F, Luscher TF 1998 Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 32(Suppl 3):554-561
25. Westerbacka J, Vehkavaara S, Bergholm R, Wilkinson I, Cockcroft J, Yki-Järvinen H 1999 Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes 48:821-827
26. Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T 1995 Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria. Arterioscler Thromb Vasc Biol 15:1114-1120
27. Hogikyan RV, Galecki AT, Pitt B, Halter JB, Greene DA, Supiano MA 1998 Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity. J Clin Endocrinol Metab 83:1946-1952
28. Steinberg HO, Shaker H, Leaming R, Johnson A, Brechtel G, Baron AD 1996 Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610
29. Ferri C, Desideri G, Balconcini R, Bellini C, De Angelis C, Mazzocchi C, Santucci A 1998 Early activation of vascular endothelium in nonobese, non-diabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes 47:660-667
30. Anastasiou E, Lekakis JP, Alevlzaki M, Papamichael CM, Megas J, Souvatzoglou A, Stamatelopoulos SF 1998 Impaired endothelium-dependent vasodilation in women with previous gestational diabetes. Diabetes Care 21:2111-2115
31. Simon D, Goretzki PE, Lollert A, Roher HD 1993 Persistent hypertension after successful adrenal operation. Surgery 114:1189-1195
32. Suzuki T, Shibata H, Ando T, Kurihara I, Kobayashi S, Hayashi K, Hayashi M, Kawabe H, Saito I, Murai M, Saruta T 2000 Risk factors associated with persistent postoperative hypertension in Cushing's syndrome. Endocr Res 26:791-795